Novartis AG

-

Stock Issuer and Owners

Home | Sign Up | Log In
Message
Happy Holidays!! thanks for using AUM13F!!
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Novartis AG
TickerNVS
CIK #0001114448
CUSIP66987V109
SectorLife Sciences - Pharmaceutical Preparations
AddressLichtstrasse 35, Basel, CH 4056
Source [EDGAR]
CIK Filing 2011 - 2025
[0001114448] 3
[0001114448] 4
[0001114448] 5
[0001114448] 6-K
[0001114448] SC 13D
[0001114448] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC Novartis AG [2025-07-17] 0.0
Novartis AG Morphosys AG [2024-04-18] 11.56
BlackRock Inc Novartis AG [2022-02-04] 5.7
Novartis AG Restorbio Inc [2018-02-14] 7.2
Novartis AG Advanced Accelerator Applications Sa [2018-02-01] 8.7
Novartis AG XOMA Corp [2017-09-05] 6.6
Novartis AG Arrowhead Research Corp [2016-02-12] 5.57
Novartis AG Aduro Biotech Inc [2015-04-28] 5.21
Form 3/4/5 Filer 2011 - 2025
Novartis Pharma AG
Precision Biosciences Inc
Novartis AG
Cellular Biomedicine Group, Inc.
Poseida Therapeutics, Inc.
Novartis Bioventures Ltd
Akouos, Inc.
Galera Therapeutics, Inc.
Forma Therapeutics Holdings, Inc.
Bicycle Therapeutics PLC
Whitehawk Therapeutics, Inc.
Rein Therapeutics, Inc.
Novartis Institutes for BioMedical Research, Inc.
Intellia Therapeutics, Inc.
Altimmune, Inc.
AveXis, Inc.
Spyre Therapeutics, Inc.
Surface Oncology, Inc.
Q32 Bio Inc.
Ra Pharmaceuticals, Inc.
Kineta Inc/DE
Eledon Pharmaceuticals, Inc.
Idenix Pharmaceuticals Inc
Alnylam Pharmaceuticals Inc
Form 13F Holdings
Firm Period DFND Voting Shares
Dodge & Cox [2025-06-30] SOLE 10,230,029 10,647,629
PRIMECAP Management Co/CA/ [2025-06-30] SOLE 10,283,824 10,401,434
Dimensional Fund Advisors LP [2025-06-30] SOLE 7,873,602 7,962,896
Morgan Stanley [2025-06-30] DFND 3,482,091 7,559,488
Fisher Asset Management LLC [2025-06-30] DFND 6,250,790 7,121,414
Loomis Sayles & Co L P [2025-06-30] DFND 4,595,860 5,581,576
Bank of America Corp /DE/ [2025-06-30] DFND 907,004 4,527,488
Franklin Resources Inc [2025-06-30] DFND 4,239,130 4,239,426
Goldman Sachs Group Inc [2025-06-30] DFND 2,246,932 2,541,872
Wellington Management Group LLP [2025-06-30] DFND 0 2,502,395
BlackRock, Inc. [2025-06-30] SOLE 1,969,710 2,321,155
Renaissance Technologies LLC [2025-06-30] SOLE 2,298,151 2,298,151
Principal Financial Group Inc [2025-06-30] DFND 2,291,374 2,291,374
Janus Henderson Group PLC [2025-06-30] DFND 0 2,178,822
Northern Trust Corp [2025-06-30] DFND 1,765,313 1,967,600
Wells Fargo & Company/MN [2025-06-30] DFND 163,232 1,863,268
Susquehanna International Group LLP [2025-06-30] OTR 5,074 1,838,274
Envestnet Asset Management Inc [2025-06-30] SOLE 1,736,891 1,736,891
State Street Corp [2025-06-30] DFND 49,070 1,597,830
FMR LLC [2025-06-30] DFND 114,560 1,540,963
Marshall Wace LLP [2025-06-30] OTR 0 1,431,814
UBS Group AG [2025-06-30] DFND 209,059 1,391,926
Scharf Investments LLC [2025-06-30] SOLE 563,330 1,262,444
Chevy Chase Trust Holdings, LLC [2025-06-30] DFND 0 1,135,326
Dimensional Fund Advisors LP [2025-06-30] DFND 0 1,097,999
Millennium Management LLC [2025-06-30] SOLE 840,771 1,010,171
Raymond James Financial Inc [2025-06-30] DFND 362,762 927,314
Balyasny Asset Management LP [2025-06-30] SOLE 876,956 876,956
Earnest Partners LLC [2025-06-30] SOLE 637,518 850,207
Clark Capital Management Group Inc [2025-06-30] SOLE 827,087 830,970
Prev | Page 1 | Next
Terms | Privacy | Guide
tony@aum13f.com